about
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersGlucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseMBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseAltered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.Endocrine manifestations of chronic HCV infection.Usefulness of fecal calprotectin determination in pediatric intestinal diseases.Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α.Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis.Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic Acid Breath Test.Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.Fecal calprotectin: beyond intestinal organic diseases.Considerations on meta-analyses regarding the association between long non-coding RNA and neoplasms.Liver fibrosis: the 2017 state of art.Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.From mesenchymal stem cells to chondrocytes: a comment.Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.Serum zonulin in patients with inflammatory bowel disease: a pilot studyFecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disordersHow to diagnose NAFLD in 2016Role of miR-503 in gastric cancerA Comment on the LetterHypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoproteinMyostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activationOn-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel DiseasesPrevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without SteatohepatitisCirculating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver DiseaseCrosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver diseaseIs the pattern of liver disease etiology changing in China?Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective studyOncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
P50
Q26749045-679E5311-E1F2-4D6D-9246-2841760CEBB0Q28539434-B017A552-530D-4E95-A5EF-A365EBFB6EE4Q33866766-CB175C4F-FC61-4B06-8D5C-5C9D67CB201FQ34255562-E5ECE806-4F5B-421D-B148-A60FA1A5C37DQ35810018-6C743257-026C-44CB-BB2F-DBBA5066EC9EQ36138443-959B46AF-A1C4-456C-85B4-168BAB4762E0Q38287516-47D783F0-B677-4E95-8B67-D80437CC8E27Q38583008-9DC1DC41-7AD4-48FD-ADD3-22C31F10A820Q38964466-B59AABBC-BED6-400A-9B97-AC0BFD66C91DQ40181436-82E545B1-715C-416E-BCA8-134D066DF160Q40557516-1FB1FF0C-E123-42E3-A14B-2AE0C9076D7DQ40931840-C67C9715-D421-484F-9D55-F191DF777707Q41311538-AACC0083-7D25-465B-A13B-72613A6C4613Q41686441-D1D2C407-F3D6-4953-A0D7-981D742072BDQ42153080-93736515-592D-44CA-B538-A75F0416AA4FQ42987060-C2BB2B47-5AE9-4EAC-B699-56CF30A2F4A5Q47803154-15A1AAEC-B042-41E1-B8EE-43918EC624A9Q47833669-E246ADAB-4A24-433C-8944-3BD932A960DFQ48196520-C3B91171-91D7-46D4-94CB-E055EC00D864Q49688049-41F9B831-53D7-44EC-8A44-E5ACA9BD991FQ50146758-8D0DD170-8F28-4181-8A28-26521F50B62DQ50208583-53D4487F-1238-48E9-8064-7AF7132BD3C4Q50561205-C4DCA2AA-0B5E-4218-A2BC-D1809F04BD3DQ52873745-9DA58EBF-66F8-4DA5-8291-C0EFC67935A0Q53534080-D25E7038-E1DE-48D5-A858-4CFF6140F230Q53813254-903975CC-20BA-4AAD-A0F6-9D8470331006Q57124768-AC50F433-073F-4EF4-A97D-83ECB72B9888Q85908507-826F7A2E-A426-4006-A747-25E9AB8E2255Q87868541-54E80A13-96A1-4D63-9AFF-9E13C6EC8EB9Q88947430-68263A90-0D8F-4900-A716-9329537C8F71Q89025788-E3587EBB-48DC-4411-8D0E-6957ABE3F608Q89706481-B8675B0A-23F1-4A9A-B258-085CEAAEF76AQ90040322-39A07071-5B40-4D97-A1F1-6D293753C3F8Q90400913-74C108F5-462B-40AF-9595-24BDD47E0508Q91305972-F52224F0-3A0C-4ABE-B7CB-C1E1CF1DA523Q91626566-A5EF1C45-DD09-4762-9795-20485B340F34Q91846492-1E79BADF-B745-4A1E-85C1-D2C0EFF4C41AQ91967901-EAB39ACA-2908-4A6E-9194-B59CA6968CABQ91967916-D82A24B3-6824-4ABF-9AD0-8F6364156CA5Q92156953-EB84FD41-7867-4971-9A88-54405C229F8B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chiara Rosso
@ast
Chiara Rosso
@en
Chiara Rosso
@es
Chiara Rosso
@nl
Chiara Rosso
@sl
type
label
Chiara Rosso
@ast
Chiara Rosso
@en
Chiara Rosso
@es
Chiara Rosso
@nl
Chiara Rosso
@sl
prefLabel
Chiara Rosso
@ast
Chiara Rosso
@en
Chiara Rosso
@es
Chiara Rosso
@nl
Chiara Rosso
@sl
P106
P21
P31
P496
0000-0001-6518-7089